Journal Reprints: Risk-Mitigating Info Should Be “At Least As Persuasive” As Existing Sources
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA quickly drafts guidance in response to stakeholder questions related to distribution of articles on unapproved uses.